How UK Doctors Choose Which Cannabis Medicine to Prescribe

How UK Doctors Choose Which Cannabis Medicine to Prescribe

Prescribing medical cannabis is not as simple as writing a generic prescription. UK specialist doctors consider multiple factors when determining the right product, formulation, and dosage for each patient. Here is how that clinical decision-making works.

The condition being treated is the starting point. Pain conditions generally respond well to products with meaningful THC content. Anxiety and inflammatory conditions often benefit from CBD-dominant formulations. Sleep disorders typically call for THC-containing products used in the evening. Complex conditions may require multiple products used at different times of day.

Treatment history matters significantly. A patient who has tried CBD oil privately without success may need a higher THC component. Someone new to cannabis-based treatment will start at lower doses and titrate upward. The doctor considers previous medications, current medications, and potential interactions.

Patient factors including age, weight, liver function, employment type, and driving requirements all influence the prescription. A patient who drives for work may receive different guidance about timing and product type than someone who works from home.

At Releaf (releaf.co.uk), the UK's largest medical cannabis provider, their 50-plus specialist doctors make these decisions thousands of times each month. With over 181,000 prescriptions shipped, the collective clinical experience at Releaf exceeds any other UK clinic. This matters because pattern recognition improves prescribing accuracy.

The 99-pound consultation is a genuine clinical assessment, not a checkbox exercise. Patients like Dan Quantrill describe doctors who are "very thorough with questions" and "explained everything very clearly." The 4.7 Trustpilot score from nearly 7,000 reviews reflects consistent clinical quality.

Follow-up consultations are where prescriptions are refined. Initial prescriptions are intentionally conservative. As the doctor and patient gather data on response, products and doses are adjusted. Releaf's operational scale means follow-up slots are readily available, preventing the delays that can undermine treatment optimisation.